This report covers one of a series of studies dealing with the turnover and tissue distribution of lead in amyotrophic lateral sclerosis (ALS) . The work started as a result of several earlier observations on a relationship between the disease and previous exposure to heavy metals, particularly lead (Wilson, 1907; Currier and Haerer, 1968; Campbell et al., 1970; Felmus et al., 1976) . One aim of our studies is to test whether lead is pathologically available to the motor neurones in the disease, and we recently found increased levels of lead in cerebrospinal fluid in patients with ALS as compared with control subjects (Conradi et al., 1976) .
The transport of a substance from plasma to the cell bodies of lower motor neurones via the motor endplates and the retrograde axoplasmic flow has recently been demonstrated in the rat in experiments using the enzyme horseradish peroxidase (Broadwell and Brightman, 1976) . This route of entry to the central nervous system short circuits the blood-brain barrier, and accordingly the motor neurones might be damaged by substances from plasma transported in this way. Such a mechanism could be operating in ALS, in view of the selective involvement of motor neurones in this disease. The neurotoxicity of lead is wellknown from earlier work (see Waldron and Stofen, 1974) .
There are few reports on the concentration of lead in plasma of normal individuals, probably because of earlier methodological problems. The question has to our knowledge not been studied in ALS. Only a small fraction of the lead found in whole blood is considered to be present in plasma, and plasma levels ranging between 1 and 10 ,tg/dl have been reported in normal subjects (Butt et al., 1964; McRoberts, 1973; Rosen and Trinidad, 1974) . After the addition of various amounts of lead to blood in vitro, only about 1 ,ug/dl was found to be retained in plasma after 15 min (Clarkson and Kench, 1958) . Interestingly, the plasma levels of lead have been claimed to be constant over a wide range of lead concentration in whole blood (Butt et al., 1964; Rosen and Trinidad, 1974) . This suggests a protective action of the erythrocytes against overloading of the plasma with lead. The binding of lead to plasma constituents is not known in detail, but it has been suggested that the metal is bound both to small molecules, such as polypeptides, and to proteins (Griffin and Matson, 1972) . 389 In the present study the plasma levels of lead were determined by flameless atomic absorption spectrophotometry in 16 patients with amyotrophic lateral sclerosis and 18 control subjects with non-degenerative neurological diseases.
Patients and methods
Amyotrophic lateral sclerosis was diagnosed on conventional clinical grounds. Patients having symptoms predominantly from either peripheral, central, or bulbar motor neurones were included. The ages of the ALS patients and ages and diagnoses of the patients in the control group are given in the Table. Blood was obtained through antecubital venous puncture using lead-free syringes, and collected in heparinised lead-free test tubes. For the determination of lead in plasma, 10 ml of blood was immediately centrifuged at 5000 rpm for 10 min. The plasma samples were stored for two to 12 weeks before analysis. In the ALS group, the lead content of whole blood was also determined, using the method of Einarsson and Lindstedt (1969) . Lead in plasma was determined with an atomic absorption spectrophotometer model AA-6 (Varian Tectron, Melbourne, Australia) with a carbon rod CRA-63 and a temperature control unit, measuring the temperature of the carbon rod with a photodiode. A deuterium lamp was used for background correction. A hollow cathode lead lamp (Varian) was used and operated at 5 mA with use of the lead 217.0 nm resonance line. A slit width of 1.0 nm was used. A standard deviation of +l10% for within day runs and -+f15% for runs between days was estimated. The samples of plasma lead concentrations in the two groups were compared using the U-test of Mann and Whitney (see Siegel, 1956 ).
Results
The results of the determinations are shown in the Table and diagrammatically in the Figure. The lead concentration in plasma of all the samples (Witschii, 1965) . Obviously, several other parameters than the whole amount of the results in the Table. of lead present in plasma at a given moment are relevant to the availability of the metal to various
.nd 1.0 ,tg/dl. The values for tissues. Further discussions on this point must,
were concentrated around therefore, await a more thorough knowledge on tre the lowest values of the the mechanisms of binding of lead in blood. It range was larger in the ALS should also be pointed out that since nearly all statistically significant differ-the lead in whole blood is bound to the erythroen the groups. The values for cytes, damage to these cells during the preparation were normal. is critical. Accordingly, reported differences in plasma lead levels between samples could be the result of a different vulnerability of the erythrocytes. The plasma levels of lead reported here for both normal subjects and patients with ALS were low, and this puts high demands on the sensitivity of the method of analysis. Despite the errors of detection present at these very low levels, the findings were highly reproducible, and the differences between the individual estimates on each sample were small. Our values from the control material were considerably lower than those reported earlier in normal subjects (Butt et al., 1964; McRoberts, 1973; Rosen and Trinidad, 1974) . The difference might have to do with methodological factors since none of the earlier estimations was performed using a flameless method. Further, the accuracy of the procedure used at centrifugation of the blood is important, since it is well-known that the lead can easily be removed from the erythrocytes (Clarkson and Kench, 1958; Witschii, 1965) .
It has been argued that the concentration of lead in plasma, rather than that in whole blood, is the most relevant to the action of metal on various tissues-for example, in lead intoxication (McRoberts, 1973) -despite the plasma pool of lead The retrograde axoplasmic flow of lower motor neurones has been shown to transport various substances, mainly macromolecules, from the motor endplates to the cell bodies of these neurones (Kristensson, 1975) . The fact that macromolecules can enter this route from plasma has been shown by intravenous horseradish peroxidase injections (Broadwell and Brightman, 1976) , where the spinal cord showed a nearly selective labelling of the motor neurones. This similarity between enzyme distribution and the involvement of neurones in ALS is striking and merits further consideration, especially from the standpoint of noxious substances gaining access to the retrograde flow.
As shown earlier for horseradish peroxidase (Heuser and Reese, 1973) , the substance to be transported by the retrograde flow enters the endplates through a process of pinocytosis, the capacity of which parallels the turnover of synaptic vesicles. Obviously, the concentration of the substance to be taken up in interstitial fluid of skeletal muscle is pertinent to the uptake, regardless of whether the substance originates from plasma or from skeletal muscle. Further, the uptake of substance in the endplates of individual motor neurones will be influenced by impulse activity and total endplate surface formed by the neurone. Motor neurones supplying large motor units will then show a large surface of uptake of foreign substance. If we assume a constant load of a foreign noxious substance provoking degeneration of motor neurones and being taken up by the motor and endplates, this would explain a progressive involvement of motor neurones. Because of collateral reinnervation of denervated muscle fibres (Edds, 1953 ) the endplate surface of regenerating motor neurones will increase, which would tend to increase their uptake.
It must also be considered whether damage to descending pathways going to motor neurones taking up a noxious substance can be caused by trans-synaptic spread and further transport through retrograde axoplasmic flow. Actually, trans-synaptic spread between adjacent motor neurones must also be considered, according to recent observations in our laboratory (Cullheim et al., 1977) . Spread of foreign substances between central neurones has earlier been observed by intraneuronal injection of dyes (Zieglgansberger and Reiter, 1974 
